Article info

Download PDFPDF
Experimental therapeutics: preclinical
B11 Targeting the Nrf2 pathway in Huntington's disease: fumaric acid esters as a new therapeutic option in neurodegeneration?

Citation

Ellrichmann G, Lee D, Reick C, et al
B11 Targeting the Nrf2 pathway in Huntington's disease: fumaric acid esters as a new therapeutic option in neurodegeneration?

Publication history

  • First published November 16, 2010.
Online issue publication 
November 16, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.